drugset / Trial / NCT01980498
PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy
Phase 3
Withdrawn
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Consorzio Mario Negri Sud · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The primary objective of the present phase IIIb study is to assess the efficacy of FPNS compared with Physician Choice-Usual Care (PC-UC) in the reduction of swallowing predictable BTP in head and neck cancer patients undergoing radiotherapy with or without chemotherapy.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 800 ug | Intranasal |
Indications
No indication recorded.